Chiappelli, Joshua
Quinton, Maria S.
Volfson, Dmitri
Cwik, Michael
Marshall, Wyatt http://orcid.org/0000-0002-6661-3833
Bruce, Heather
Goldwaser, Eric
Kvarta, Mark http://orcid.org/0000-0002-1093-1648
Summerfelt, Ann
Kochunov, Peter
O’Donnell, Patricio http://orcid.org/0000-0001-7788-624X
Hong, Liyi Elliot
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23MH112010)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB015611)
Article History
Received: 22 April 2020
Accepted: 3 September 2020
First Online: 20 November 2020
Competing interests
: Dr. Hong has received or plans to receive research funding or consulting fees from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho Pharmaceutical, Luye Pharma, Sound Pharma, Takeda, Heptares, Pfizer, and Regeneron. Drs. Cwik, O’Donnell, Quinton, and Volfson are employees of Takeda Pharmaceuticals. All other authors declare no competing interests.